Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Neumora Therapeutics, Inc. (NMRA) had Non-Operating Income/Expense of $-0.89M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-43.08M |
|
-- |
|
-- |
|
$42.19M |
|
$-42.19M |
|
|
Non-Operating Income/Expense |
$-0.89M |
$-43.08M |
|
$-43.08M |
|
$-43.08M |
|
$-43.08M |
|
$-43.08M |
|
$-43.08M |
|
$-42.19M |
|
$-41.79M |
|
185.16M |
|
185.16M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$124.87M |
|
$0.03M |
|
$0.38M |
|
$125.25M |
|
$27.78M |
|
$52.91M |
|
$52.95M |
|
$80.73M |
|
$44.52M |
|
$44.52M |
|
$44.52M |
|
186.85M |
|
| Cash Flow Statement Financials | |
$-85.93M |
|
$0.07M |
|
$20.16M |
|
$182.53M |
|
$116.83M |
|
$-65.70M |
|
$14.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.50 |
|
-- |
|
-- |
|
0.54 |
|
1.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-85.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-96.77% |
|
-96.77% |
|
-34.40% |
|
-44.22% |
|
$0.24 |
|
$-0.46 |
|
$-0.46 |
|